| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY |
|---|---|---|---|---|
| Revenue | $19.06M | $25.43M | $32.21M | $21.77M |
| Cost of Revenue | $14.40M | $14.98M | $19.10M | $13.49M |
| Gross Profit | $4.66M | $10.45M | $13.11M | $8.29M |
| Operating Expenses | $11.10M | $15.01M | $9.85M | $5.98M |
| R&D | $340.95K | $549.37K | $292.72K | – |
| SG&A | $7.62M | $7.61M | $3.93M | $2.31M |
| Operating Income | -$6.44M | -$4.56M | $3.26M | $2.31M |
| Interest Expense | – | $405.62K | $152.05K | $100.39K |
| Tax Expense | $328.68K | $336.17K | $1.18M | $821.90K |
| Net Income | -$9.26M | -$5.29M | $1.90M | $1.38M |
| EPS (basic) | -8.3800 | -1.1000 | 0.0900 | 0.0600 |
| EPS (diluted) | -8.3800 | – | – | – |
| Shares (diluted) | $1.10M | $4.82M | $22.00M | $22.00M |